-

AscellaHealth Launches Expanded Website: User-Friendly Content on Global Specialty Pharmacy and Healthcare Services for Patients, Payers, Life Sciences and Providers

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global specialty pharmacy and healthcare solutions company, announces the unveiling of a more robust, streamlined website with easy-to-navigate content featuring its innovative programs and services for key market sectors: patients – the focal point for all AscellaHealth initiatives; payers, including health plans and employers; life sciences, spanning pharmaceutical and biotech manufacturers; and providers comprising health systems, prescribers and specialty pharmacies. The newly designed website supports innovative opportunities to deliver the best possible experience for patients with chronic or complex conditions requiring specialty medications or cell and gene therapies, as well as alternative financial solutions that address the steep cost of therapies.

“By enhancing our digital presence and customizing the content for key audience stakeholders, we take another step forward in positioning our fast-growth company as a leader in end-to-end Specialty Pharmaceutical services that improve access to medications for patients, optimize clinical outcomes and pioneer payment and pricing models that adequately balance access and affordability, while sufficiently valuing curative therapies,” says Dea Belazi, president and CEO, AscellaHealth. “Our comprehensive HUB services for life science companies and clinical patient support capabilities help to simplify communications between prescribers, patients and pharmacies, improve access and decrease medication fulfillment times. We’re also very proud of our custom and innovative copay and financial assistance solutions which enhance patient affordability of high-cost specialty medications to increase therapy adherence and brand loyalty.”

AscellaHealth’s state-of-the-art programs and services include:

  • Limited distribution drug fulfillment
  • Pre-commercialization and market access
  • Group purchasing services and drug rebate programs
  • Patient Support and HUB Services
  • Financial and copay assistance programs
  • Specialty Pharmacy and Medical Benefit Management

Belazi adds, “This redesigned website gives visitors an inside look at AscellaHealth’s patient-first solutions and demonstrates our industry leadership in Specialty Pharmacy. Newcomers to our site, as well as longtime clients and stakeholders, will appreciate our expanded programs to help manufacturers extend the value of their products and increase outcomes, while supporting payers and providers in their efforts to reduce administrative waste and manage high-cost specialty spend.”

Visit the newly designed website at www.AscellaHealth.com.

About AscellaHealth LLC

AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving patients, payers, life sciences and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. An Inc. 5000 2021 winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Visit www.AscellaHealth.com.

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

AscellaHealth


Release Summary
AscellaHealth Expanded Website: Content on Global Specialty Pharmacy & Healthcare Services for Patients, Payers, Life Sciences and Providers
Release Versions

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

Social Media Profiles
More News From AscellaHealth

AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies...

AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies

DUBLIN--(BUSINESS WIRE)--AscellaHealth, a global partner delivering customisable solutions for the specialty pharmaceutical industry, proudly announces its role as Gold Sponsor of the World Orphan Drug Congress Europe (WODC), 22-25 October 2024, Barcelona, Spain. During the event, AscellaHealth will exhibit its comprehensive suite of end-to-end solutions proven to streamline the specialty pharmaceutical commercialisation process for life science manufacturers worldwide. These solutions align wi...

AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Issues Impacting Life Sciences & Payers within the Specialty Healthcare...
Back to Newsroom